Chimeric Antigen Receptor Structure and Manufacturing of Clinical Grade CAR Engineered Cells using Different Bioreactors.
Sign Up to like & getrecommendations! Published in 2022 at "Hematology/oncology and stem cell therapy"
DOI: 10.56875/2589-0646.1048
Abstract: Increasing success of adaptive cell therapy (ACT), such as genetically engineered T cells to express chimeric antigen receptors (CARs) proven to be highly significant technological advancements and impressive clinical outcomes in selected haematological malignancies, with… read more here.
Keywords: engineered cells; car; car engineered; clinical grade ... See more keywords